PortfoliosLab logo
PBYI vs. TPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PBYI and TPH is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PBYI vs. TPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Puma Biotechnology, Inc. (PBYI) and Tri Pointe Homes, Inc. (TPH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PBYI:

-0.26

TPH:

-0.64

Sortino Ratio

PBYI:

0.04

TPH:

-0.85

Omega Ratio

PBYI:

1.01

TPH:

0.90

Calmar Ratio

PBYI:

-0.23

TPH:

-0.62

Martin Ratio

PBYI:

-0.78

TPH:

-1.16

Ulcer Index

PBYI:

28.90%

TPH:

20.18%

Daily Std Dev

PBYI:

74.16%

TPH:

33.62%

Max Drawdown

PBYI:

-99.40%

TPH:

-70.06%

Current Drawdown

PBYI:

-98.82%

TPH:

-36.07%

Fundamentals

Market Cap

PBYI:

$160.58M

TPH:

$2.71B

EPS

PBYI:

$0.78

TPH:

$4.50

PE Ratio

PBYI:

4.15

TPH:

6.63

PEG Ratio

PBYI:

0.03

TPH:

0.83

PS Ratio

PBYI:

0.69

TPH:

0.63

PB Ratio

PBYI:

1.66

TPH:

0.81

Total Revenue (TTM)

PBYI:

$232.71M

TPH:

$4.28B

Gross Profit (TTM)

PBYI:

$168.48M

TPH:

$995.87M

EBITDA (TTM)

PBYI:

$50.40M

TPH:

$570.50M

Returns By Period

In the year-to-date period, PBYI achieves a 6.07% return, which is significantly higher than TPH's -17.68% return. Over the past 10 years, PBYI has underperformed TPH with an annualized return of -33.75%, while TPH has yielded a comparatively higher 7.47% annualized return.


PBYI

YTD

6.07%

1M

7.48%

6M

7.83%

1Y

-19.12%

3Y*

20.69%

5Y*

-22.69%

10Y*

-33.75%

TPH

YTD

-17.68%

1M

-3.27%

6M

-29.96%

1Y

-22.10%

3Y*

15.17%

5Y*

16.92%

10Y*

7.47%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Puma Biotechnology, Inc.

Tri Pointe Homes, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

PBYI vs. TPH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBYI
The Risk-Adjusted Performance Rank of PBYI is 3737
Overall Rank
The Sharpe Ratio Rank of PBYI is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of PBYI is 3838
Sortino Ratio Rank
The Omega Ratio Rank of PBYI is 3838
Omega Ratio Rank
The Calmar Ratio Rank of PBYI is 3838
Calmar Ratio Rank
The Martin Ratio Rank of PBYI is 3434
Martin Ratio Rank

TPH
The Risk-Adjusted Performance Rank of TPH is 1616
Overall Rank
The Sharpe Ratio Rank of TPH is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of TPH is 1616
Sortino Ratio Rank
The Omega Ratio Rank of TPH is 1717
Omega Ratio Rank
The Calmar Ratio Rank of TPH is 1313
Calmar Ratio Rank
The Martin Ratio Rank of TPH is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PBYI vs. TPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Puma Biotechnology, Inc. (PBYI) and Tri Pointe Homes, Inc. (TPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PBYI Sharpe Ratio is -0.26, which is higher than the TPH Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of PBYI and TPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

PBYI vs. TPH - Dividend Comparison

Neither PBYI nor TPH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PBYI vs. TPH - Drawdown Comparison

The maximum PBYI drawdown since its inception was -99.40%, which is greater than TPH's maximum drawdown of -70.06%. Use the drawdown chart below to compare losses from any high point for PBYI and TPH.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

PBYI vs. TPH - Volatility Comparison

Puma Biotechnology, Inc. (PBYI) has a higher volatility of 20.90% compared to Tri Pointe Homes, Inc. (TPH) at 8.17%. This indicates that PBYI's price experiences larger fluctuations and is considered to be riskier than TPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PBYI vs. TPH - Financials Comparison

This section allows you to compare key financial metrics between Puma Biotechnology, Inc. and Tri Pointe Homes, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20212022202320242025
46.01M
723.43M
(PBYI) Total Revenue
(TPH) Total Revenue
Values in USD except per share items

PBYI vs. TPH - Profitability Comparison

The chart below illustrates the profitability comparison between Puma Biotechnology, Inc. and Tri Pointe Homes, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%90.0%20212022202320242025
77.1%
22.2%
(PBYI) Gross Margin
(TPH) Gross Margin
PBYI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Puma Biotechnology, Inc. reported a gross profit of 35.45M and revenue of 46.01M. Therefore, the gross margin over that period was 77.1%.

TPH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tri Pointe Homes, Inc. reported a gross profit of 160.80M and revenue of 723.43M. Therefore, the gross margin over that period was 22.2%.

PBYI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Puma Biotechnology, Inc. reported an operating income of 3.98M and revenue of 46.01M, resulting in an operating margin of 8.7%.

TPH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tri Pointe Homes, Inc. reported an operating income of 72.00M and revenue of 723.43M, resulting in an operating margin of 10.0%.

PBYI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Puma Biotechnology, Inc. reported a net income of 2.97M and revenue of 46.01M, resulting in a net margin of 6.5%.

TPH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tri Pointe Homes, Inc. reported a net income of 64.04M and revenue of 723.43M, resulting in a net margin of 8.9%.